Antibiotics, Antibiotic Alternatives, and Combination Antimicrobial Therapy (Volume 2)
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: 28 February 2025 | Viewed by 7070
Special Issue Editors
Interests: combinational antibacterial therapy; antibacterial resistance; pharmacokinetics and pharmacodynamics of antibacterial agents
Special Issues, Collections and Topics in MDPI journals
2. Laboratory of Veterinary Pharmacokinetics and Pharmacodynamics, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea
Interests: disinfectants; veterinary hygiene; animal food safety
Special Issue Information
Dear Colleagues,
Antibiotics play a significant role in treating and preventing infections caused by microbial agents if used precisely. However, due to the fast development of drug resistance, treatment becomes ineffective and risks the livelihood of humans and animals. To worsen the situation, the invention and production of new antibiotics are at an alarmingly low rate.
Some of the factors which contribute to the development and spread of antimicrobial resistance include the presence of resistant microbial strains in the environment, antimicrobial usage and other related aspects in the community, and antimicrobial use in food-producing animals [1].
Hence, intervention mechanisms should be designed to combat antibacterial resistance globally. Alternatives to the currently available drugs or other means of interventions, including drug combinations [2], are required to limit drug resistance in microbial agents. Furthermore, pharmacokinetic and pharmacodynamic integration studies could play a significant role in increasing the efficacy and potency of currently available drugs.
Hence, the focus of this Special Issue (Volume II), titled “Antibiotics, Antibiotic Alternatives, and Combination Antimicrobial Therapy (Volume 2)”, in the journal Pathogens, is to promote studies that focus on the intervention mechanisms of antimicrobial resistance, provide antibacterial alternatives and antibacterial enhancers to the currently available antimicrobials, study the integration of pharmacokinetics and pharmacodynamics, including the efficacy and dosage formulation of the currently available antibiotics, and combination therapies, which are effective against drug-resistant pathogens. The Special Issues (Volume 2) will also cover antiseptics and disinfectants that kill viruses, bacteria, fungi, and ectoparasites [3].
-
Prestinaci, F.; Pezzotti, P.; Pantosti, A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health 2015, 109, 309–318, doi: 10.1179/2047773215Y.0000000030.
-
Birhanu, B.T.; Lee, E.-B.; Park, S.-C. Evaluation of the pharmacokinetic-pharmacodynamic integration of marbofloxacin in combination with methyl gallate against Salmonella Typhimurium in rats. PLoS ONE, 2020, 15, e0234211, doi: 10.1371/journal.pone.0234211.
-
Rhee, C.H.; Park, S.-C.; Her, M.; Jeong, W. Surrogate Selection for Foot-and-Mouth Disease Virus in Disinfectant Efficacy Tests by Simultaneous Comparison of Bacteriophage MS2 and Bovine Enterovirus Type 1. Viruses, 2022, 14, 2590, doi: 10.3390/v14122590.
Prof. Dr. Seung-Chun Park
Dr. Chae Hong Rhee
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- combinational antibacterial therapy
- antibacterial enhancers
- pharmacokinetics of antibacterial agents
- antiseptics
- disinfectants
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.